Caris Life Sciences, Stock Fundamentals
| CAI Stock | USD 26.98 0.34 1.24% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Caris Life's long-term financial health and intrinsic value.
As of now, Caris Life's Total Operating Expenses is increasing as compared to previous years. The Caris Life's current Cost Of Revenue is estimated to increase to about 281.9 M, while Interest Expense is projected to decrease to under 33.1 M. Caris | Select Account or Indicator | Build AI portfolio with Caris Stock |
Caris Life Sciences, Company Shares Outstanding Analysis
Caris Life's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Caris Life Shares Outstanding | 283.56 M |
Most of Caris Life's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Caris Life Sciences, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Caris Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Caris Life is extremely important. It helps to project a fair market value of Caris Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Caris Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Caris Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Caris Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Caris Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Caris Life Sciences, has 283.56 M of shares currently outstending. This is 94.56% higher than that of the Trading Companies & Distributors sector and significantly higher than that of the Industrials industry. The shares outstanding for all United States stocks is 50.41% higher than that of the company.
Caris Life Sciences, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Caris Life's current stock value. Our valuation model uses many indicators to compare Caris Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Caris Life competition to find correlations between indicators driving Caris Life's intrinsic value. More Info.Caris Life Sciences, is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers . As of now, Caris Life's Net Loss is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Caris Life's earnings, one of the primary drivers of an investment's value.Caris Life's Earnings Breakdown by Geography
Caris Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Caris Life's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Caris Life could also be used in its relative valuation, which is a method of valuing Caris Life by comparing valuation metrics of similar companies.Caris Life is currently under evaluation in shares outstanding category among its peers.
Caris Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Caris Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Caris Life's managers, analysts, and investors.Environmental | Governance | Social |
Caris Fundamentals
| Profit Margin | (0.60) % | ||||
| Operating Margin | (0.48) % | ||||
| Current Valuation | 8.33 B | ||||
| Shares Outstanding | 283.56 M | ||||
| Shares Owned By Insiders | 48.15 % | ||||
| Shares Owned By Institutions | 16.18 % | ||||
| Number Of Shares Shorted | 5.43 M | ||||
| Price To Earning | 17.74 X | ||||
| Price To Sales | 17.55 X | ||||
| Revenue | 412.26 M | ||||
| Gross Profit | 211.38 M | ||||
| EBITDA | (182.95 M) | ||||
| Net Income | (281.89 M) | ||||
| Cash And Equivalents | 38.81 M | ||||
| Cash Per Share | 2.26 X | ||||
| Total Debt | 424.26 M | ||||
| Debt To Equity | 2.41 % | ||||
| Current Ratio | 0.45 X | ||||
| Book Value Per Share | (18.45) X | ||||
| Cash Flow From Operations | (245.2 M) | ||||
| Earnings Per Share | (1.25) X | ||||
| Price To Earnings To Growth | 0.90 X | ||||
| Number Of Employees | 1.77 K | ||||
| Beta | 1.47 | ||||
| Market Capitalization | 7.94 B | ||||
| Total Asset | 343.73 M | ||||
| Retained Earnings | (2.47 B) | ||||
| Working Capital | 50.31 M | ||||
| Current Asset | 131.15 M | ||||
| Current Liabilities | 215.06 M | ||||
| Net Asset | 343.73 M | ||||
| Last Dividend Paid | 1.2 |
About Caris Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Caris Life Sciences,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Caris Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Caris Life Sciences, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 8.6 M | 6.7 M | |
| Total Revenue | 474.1 M | 497.8 M | |
| Cost Of Revenue | 268.5 M | 281.9 M | |
| Stock Based Compensation To Revenue | 0.04 | 0.04 | |
| Sales General And Administrative To Revenue | 0.38 | 0.40 | |
| Research And Ddevelopement To Revenue | 0.32 | 0.39 | |
| Capex To Revenue | 0.02 | 0.02 | |
| Revenue Per Share | 1.46 | 1.38 | |
| Ebit Per Revenue | (0.72) | (0.68) |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Caris Life Piotroski F Score and Caris Life Altman Z Score analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Trading Companies & Distributors space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caris Life. If investors know Caris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caris Life Sciences, is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caris Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caris Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caris Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.